Faxeladol

CAS No. 433265-65-7

Faxeladol( —— )

Catalog No. M34595 CAS No. 433265-65-7

Faxeladol, a potent adrenergic absorption inhibitor and serotonin reuptake inhibitor, is a small-molecule Opioid receptor agonist that can be used to study neurological disorders.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 955 Get Quote
5MG 1283 Get Quote
25MG 1638 Get Quote
50MG 2006 Get Quote
100MG 2520 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Faxeladol
  • Note
    Research use only, not for human use.
  • Brief Description
    Faxeladol, a potent adrenergic absorption inhibitor and serotonin reuptake inhibitor, is a small-molecule Opioid receptor agonist that can be used to study neurological disorders.
  • Description
    Faxeladol, a potent adrenergic absorption inhibitor and serotonin reuptake inhibitor, is a small-molecule Opioid receptor agonist that can be used to study neurological disorders.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Adrenergic Receptor
  • Recptor
    Adrenergic Receptor | Opioid Receptor | 5-HT Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    433265-65-7
  • Formula Weight
    233.35
  • Molecular Formula
    C15H23NO
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(N(C)C)[C@H]1[C@@H](CCCC1)C2=CC(O)=CC=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Bambuterol hydrochlo...

    A long acting beta-adrenoceptor agonist (LABA) used in the treatment of asthma.

  • RS 15385-198

    RS 15385-198 is a less active isomer of Delequamine. Delequamine is a selective alpha2-adrenergic receptor antagonist.

  • (±)-Prenalterol

    (±)-Prenalterol (H 80/62) is a new cardioselective positive inotropic compound that is an agonist of beta-2- and beta-1-adrenergic receptors and can be used to study chronic congestive heart failure.